Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aerie Pharmaceuticals (NQ: AERI )

11.79 USD -0.31 (-2.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aerie Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags NPCE AERI VRDN
From Benzinga
Aerie Pharmaceuticals, Inc. Announces the Appointment of Interim Executive Chair and Departure of Chairman and CEO
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company, today announced that it is executing its succession plan for its long-serving Chairman and CEO and that effective... 
From Business Wire News Releases
Aerie Pharmaceuticals Announces Appointment of Erik Pacyniak, Ph.D., D.A.B.T., as Director, Toxicology and Drug Disposition
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
56 Biggest Movers From Yesterday
Check out these big penny stock gainers and losersLosers Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled ... 
Tags Small Cap Penny Stocks Pre/Market Outlook
From Benzinga
Why The Future Is Cloudy For This Aerie Pharmaceuticals Drug As Shares Plummet
Aerie Pharmaceuticals missed the mark in a dry-eye disease test, leading AERI stock to plummet to a 10-month low Thursday. 
From Investor's Business Daily
Mid-Afternoon Market Update: Dow Falls 70 Points; Aerie Pharmaceuticals Shares Plunge
Toward the end of trading Thursday, the Dow traded down 0.20% to 34,745 while the NASDAQ fell 0.03% to 15,157.61. The S&P also fell, ... 
Tags Eurozone Mid/Afternoon Market Update Earnings
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As ... 
Tags VERA Benzinga AERI
From Benzinga
Mid-Day Market Update: Gold Drops Over 2%; Leap Therapeutics Shares Jump
Midway through trading Thursday, the Dow traded down 0.74% to 34,557.75 while the NASDAQ fell 0.67% to 15,060.25. The S&P also fell, ... 
Tags Eurozone Earnings LPTX
From Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the ... 
Tags LPTX MGNX TMC
From Benzinga
Why The Future Is Cloudy For This Aerie Pharmaceuticals Drug As Shares Plummet
Aerie Pharmaceuticals missed the mark in a dry-eye disease test, leading AERI stock to plummet to a 10-month low Thursday. 
From Investor's Business Daily
Mid-Morning Market Update: Markets Down; US Retail Sales Unexpectedly Increase in August
Following the market opening Thursday, the Dow traded down 0.45% to 34,657.69 while the NASDAQ fell 0.66% to 15,061.97. The S&P also ... 
Tags SBTX Small Cap Mid/Morning Market Update
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The ... 
Tags Movers INDP ACER
From Benzinga
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags OYST General AFIB
From Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) rose 59.7% to $51.30 in pre-market trading. IronNet Cybersecurity emerged as ... 
Tags MTL AGIL FLGC
From Benzinga
Aerie Pharma Reports Mixed Bag On Phase 2 Dry Eye Trial
Aerie Pharmaceuticals Inc(NASDAQ: AERI)announced topline resultsof its Phase 2b COMET-1 study evaluating AR-15512 ... 
Tags General Market News News
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Larimar Therapeutics (NASDAQ:LRMR) shares rose 10.53% to $13.75 during Wednesday's after-market session. The ... 
Tags NURO LRMR IVC
From Benzinga
Aerie Pharmaceuticals Announces Novel Dry Eye Product Candidate AR-15512 (TRPM8 Agonist) Ophthalmic Solution Achieved Statistical Significance Over Multiple Symptoms and Signs in Successful Phase 2b C
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Aerie Pharmaceuticals Announces Appointment of Carolyn McAuliffe, Senior Director, Communications
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Notable Thursday Option Activity: WKHS, GPS, AERI
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Workhorse Group Inc (WKHS), where a total of 55,041 contracts have traded so far,... 
Tags Stocks
From Market News Video
Aerie Pharmaceuticals to Participate in Upcoming Investor Conferences
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Aerie Pharmaceuticals Announces Appointment of Michael Bradley, Senior Director, Manufacturing
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Looking into Aerie Pharmaceuticals's Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q2, Aerie Pharmaceuticals (NASDAQ:AERI) posted sales of $27.18 million. ... 
Tags BZI/ROCE Market News Earnings
From Benzinga
Aerie Pharmaceuticals to Participate in the H.C. Wainwright Ophthalmology Conference
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers CohBar (NASDAQ:CWBR) shares increased by 15.5% to $1.49 during Tuesday's after-market session. At the close, CohBar's ... 
Tags Benzinga AERI NARI
From Benzinga
Aerie Pharmaceuticals, inc (AERI) Q2 2021 Earnings Call Transcript
AERI earnings call for the period ending June 30, 2021. 
Tags Market News AERI
From Motley Fool
Aerie Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
Analysts See 11% Upside For The Holdings of SMMV
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VOR IPHA NVO
From Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week endingJuly 30 amid earnings releases from big pharma companies. Most ... 
Tags CHRS MOR ANIK
From Benzinga
Aerie Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.